Security key
816212302
Cartesian Therapeutics, Inc. - COMMON-STOCK (RNAC)
CUSIP: 816212302
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / COMMON-STOCK
- Total 13F shares
- 1,855
- Total 13F value
- $1,157
- Share change
- +1,855
- SEC-reported price per share
- $0.64
- Number of holders
- 4
- Value change
- +$1,157
- Number of buys
- 4
- Shares outstanding
- 29,387,746
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
4
Top holders
4
RNAC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Cartesian Therapeutics, Inc. SEC filings
Cartesian Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 816212302
Recent filing periods:
Ownership snapshot
Top reported holders of RNAC - Cartesian Therapeutics, Inc. - COMMON-STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Artal Group S.A.
Disclosed value leader
Artal Group S.A.
Comparable rows
0/15
Latest evidence
02 Jan 2024
13F
3/4/5
Highest disclosed value: $6,299,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Artal Group S.A. has the largest disclosed position value at $6.3M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Artal Group S.A.'s linked filing trail.
Disclosed position value
Top 5
Artal Group S.A.
$6.3M
FMR LLC
$5.33M
BlackRock Finance, Inc.
$5.18M
VANGUARD GROUP INC
$4.99M
Erste Asset Management GmbH
$2.16M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Artal Group S.A. |
13F
Company
|
—
class O/S missing
|
$6,299,000
9,136,635 shares
|
— | 31 Dec 2023 |
| FMR LLC |
13F
Company
|
—
class O/S missing
|
$5,327,985
7,728,437 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$5,182,874
7,517,950 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$4,994,035
7,244,032 shares
|
— | 31 Dec 2023 |
| Erste Asset Management GmbH |
13F
Company
|
—
class O/S missing
|
$2,161,168
3,127,000 shares
|
— | 31 Dec 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$1,681,040
2,438,160 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
1,855
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
4
Q1 2024 holders
4
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend